Medline Receivables

The latest receivables for MDLN is $3.7B as of June 2026. That compares with $3.3B in the prior-year period — up 9.6% year over year. Investors often review this figure alongside Medline's historical trend and sector peers before judging valuation or financial health.

Over the past year, MDLN's receivables moved from $3.3B to $3.7B — a 9.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Medline's operating scale or balance-sheet position.

A receivables figure of $3.7B for MDLN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MDLN's receivables ($3.7B), review year-over-year change from $3.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.